Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Rosuvastatin pharmacokinetics in morbid obese patients before and after Roux-en-Y gastric bypass surgery

  • In: Poster Presentation
  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • Poster code: P-A-110-Monday
  • By: WU, Hsin-Fang (University of California-San Francisco, University of California-San Francisco, San Francisco, United States)
  • Co-author(s): Hsin-Fang Wu: Bioengineering and Therapeutic Sciences, University of California-San Francisco, San Francisco, United States
    Hideaki Okochi: Bioengineering and Therapeutic Sciences, University of California-San Francisco, San Francisco, United States
    Leslie Benet: Bioengineering and Therapeutic Sciences, University of California-San Francisco, San Francisco, United States
  • Abstract:

    Backgrounds

    Morbidly obese patients frequently present with cholesterol disorders, which are often treated with statins. A previous study demonstrated that the majority of patients undergoing roux-en-Y gastric bypass (RYGB) showed increased atorvastatin acid systemic exposure after surgery.

    Aims

    This study examined the effect of RYGB on rosuvastatin

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses